Beyond COVID-19: Industry Insiders Offer 10 Strategies For Medtech Recovery
Executive Summary
Medtech insiders offer 10 strategies for medtech companies to rethink their businesses right now.
You may also be interested in...
Philips Sales Slide In Q2 But COVID-19 Drives Growth In Connected Care
Philips reported $4.97bn in sales for the second quarter of 2020, a 6% decline compared to the second quarter of last year. While the pandemic slowed down demand across the business, Philips connected care business increased by 14% due to demand for respiratory devices.
Exec Chat: Boston Scientific’s Angelo De Rosa Forsees Digital Transformation In The COVID-19 Era
Angelo De Rosa, VP of Boston Scientific's cardiac rhythm management business in Europe, the Middle East and Africa, talked to Medtech Insight about the opportunities to accelerate digital transformation in health care during the COVID-19 crisis.
VC Deals Analysis, H1 2020: Medtech Funding Stays Apace, Cardiovascular Is King
A steady flow of venture capital into the medical device industry continued in the first half of 2020 despite the pandemic. Medtech start-ups raised more than $1.5bn with Medtech Insight tracking over 40 financial deals of $1m-and-over.